SCHEMBL2912584

SCHEMBL2912584

C[C@H](O)CNC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(F)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.40
GSK3A P49840 3/20 0.40
SCN10A Q9Y5Y9 1/20 0.39
CDK1 P06493 2/20 0.37
CCNB2 O95067 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TGFBR1 P36897 2/20 0.32
ACVR1B P36896 1/20 0.32
ACVRL1 P37023 1/20 0.32
P2RX7 Q99572 1/20 0.32
HTT P42858 2/20 0.32
LMNA P02545 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
NTRK1 P04629 2/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913229 1.00 GSK3B (0.40) GSK3BGSK3ASCN10ACDK1CCNB2
SCHEMBL2907527 0.93 TGFBR1 (0.36) GSK3BGSK3ASCN10ACDK1CCNB2
SCHEMBL2912195 0.93 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912211 0.93 TGFBR1 (0.36) GSK3BGSK3ASCN10ACDK1CCNB2
SCHEMBL2909835 0.93 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904498 0.91 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2934514 0.91 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911262 0.90 GSK3B (0.42) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907739 0.90 GSK3B (0.42) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL1216751 0.90 GSK3B (0.38) GSK3BGSK3ASCN10ACDK1CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed